Gu SX - Search Results

1

Recent discoveries in HIV-1 reverse transcriptase inhibitors.

Gu SX, Zhu YY, Wang C, Wang HF, Liu GY, Cao S, Huang L. Gu SX, et al. Curr Opin Pharmacol. 2020 Oct;54:166-172. doi: 10.1016/j.coph.2020.09.017. Epub 2020 Nov 8. Curr Opin Pharmacol. 2020. PMID: 33176248 Review.

2

Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

Ma XD, Zhang X, Dai HF, Yang SQ, Yang LM, Gu SX, Zheng YT, He QQ, Chen FE. Ma XD, et al. Among authors: gu sx. Bioorg Med Chem. 2011 Aug 1;19(15):4601-7. doi: 10.1016/j.bmc.2011.06.007. Epub 2011 Jun 15. Bioorg Med Chem. 2011. PMID: 21719299

3

Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors.

Ma XD, He QQ, Zhang X, Yang SQ, Yang LM, Gu SX, Zheng YT, Chen FE, Dai HF. Ma XD, et al. Among authors: gu sx. Eur J Med Chem. 2012 Dec;58:504-12. doi: 10.1016/j.ejmech.2012.03.032. Epub 2012 Mar 31. Eur J Med Chem. 2012. PMID: 23164656

4

A novel family of diarylpyrimidines (DAPYs) featuring a diatomic linker: Design, synthesis and anti-HIV activities.

Gu SX, Qiao H, Zhu YY, Shu QC, Liu H, Ju XL, De Clercq E, Balzarini J, Pannecouque C. Gu SX, et al. Bioorg Med Chem. 2015 Oct 15;23(20):6587-93. doi: 10.1016/j.bmc.2015.09.020. Epub 2015 Sep 11. Bioorg Med Chem. 2015. PMID: 26385446

5

Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.

Gu SX, Xue P, Ju XL, Zhu YY. Gu SX, et al. Bioorg Med Chem. 2016 Nov 1;24(21):5007-5016. doi: 10.1016/j.bmc.2016.09.025. Epub 2016 Sep 12. Bioorg Med Chem. 2016. PMID: 27658796 Review.

6

Structural modifications of diarylpyrimidines (DAPYs) as HIV-1 NNRTIs: Synthesis, anti-HIV activities and SAR.

Lu HH, Xue P, Zhu YY, Ju XL, Zheng XJ, Zhang X, Xiao T, Pannecouque C, Li TT, Gu SX. Lu HH, et al. Among authors: gu sx. Bioorg Med Chem. 2017 Apr 15;25(8):2491-2497. doi: 10.1016/j.bmc.2017.03.009. Epub 2017 Mar 6. Bioorg Med Chem. 2017. PMID: 28314514

7

Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.

Xue P, Lu HH, Zhu YY, Ju XL, Pannecouque C, Zheng XJ, Liu GY, Zhang XL, Gu SX. Xue P, et al. Among authors: gu sx. Bioorg Med Chem Lett. 2017 Apr 15;27(8):1640-1643. doi: 10.1016/j.bmcl.2017.03.009. Epub 2017 Mar 7. Bioorg Med Chem Lett. 2017. PMID: 28314598

8

Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors.

Liu G, Wang W, Wan Y, Ju X, Gu S. Liu G, et al. Int J Mol Sci. 2018 May 11;19(5):1436. doi: 10.3390/ijms19051436. Int J Mol Sci. 2018. PMID: 29751616 Free PMC article.

9

Docking-based 3D-QSAR and pharmacophore studies on diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Liu G, Wan Y, Wang W, Fang S, Gu S, Ju X. Liu G, et al. Mol Divers. 2019 Feb;23(1):107-121. doi: 10.1007/s11030-018-9860-1. Epub 2018 Jul 26. Mol Divers. 2019. PMID: 30051344

10

Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors.

Gu SX, Lu HH, Liu GY, Ju XL, Zhu YY. Gu SX, et al. Eur J Med Chem. 2018 Oct 5;158:371-392. doi: 10.1016/j.ejmech.2018.09.013. Epub 2018 Sep 6. Eur J Med Chem. 2018. PMID: 30223123 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters